POTENZA, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 16.375
EU - Europa 6.848
AS - Asia 2.395
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 21
AF - Africa 11
OC - Oceania 10
Totale 25.681
Nazione #
US - Stati Uniti d'America 16.287
GB - Regno Unito 2.328
IT - Italia 1.549
SE - Svezia 992
CN - Cina 845
DE - Germania 598
HK - Hong Kong 512
SG - Singapore 480
UA - Ucraina 345
FI - Finlandia 309
TR - Turchia 237
FR - Francia 195
BG - Bulgaria 160
IN - India 83
ID - Indonesia 79
CA - Canada 61
BE - Belgio 57
CZ - Repubblica Ceca 57
RU - Federazione Russa 55
IE - Irlanda 48
VN - Vietnam 45
NL - Olanda 30
IR - Iran 24
KR - Corea 24
LT - Lituania 23
BZ - Belize 22
EU - Europa 18
MY - Malesia 18
JP - Giappone 17
RO - Romania 13
PL - Polonia 11
AU - Australia 10
CH - Svizzera 10
ES - Italia 10
SI - Slovenia 9
CL - Cile 7
DK - Danimarca 7
PH - Filippine 7
SK - Slovacchia (Repubblica Slovacca) 7
AT - Austria 6
PT - Portogallo 6
GR - Grecia 5
BR - Brasile 4
MK - Macedonia 4
MX - Messico 4
NG - Nigeria 4
NO - Norvegia 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
IQ - Iraq 3
PE - Perù 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
IL - Israele 2
LU - Lussemburgo 2
MD - Moldavia 2
OM - Oman 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GN - Guinea 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
MA - Marocco 1
MZ - Mozambico 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 25.681
Città #
Fairfield 2.629
Southend 1.888
Woodbridge 1.514
Ashburn 1.424
Chandler 1.328
Houston 1.250
Seattle 1.011
Ann Arbor 891
Wilmington 836
Cambridge 832
Nyköping 664
Jacksonville 655
Dearborn 588
Hong Kong 505
Modena 360
Singapore 302
San Diego 245
New York 236
Beijing 235
Helsinki 188
Princeton 177
Sofia 159
Eugene 135
Izmir 133
Fremont 123
Bologna 117
Milan 106
Bremen 101
London 94
Jakarta 76
Redwood City 66
Boardman 63
Shanghai 62
Des Moines 59
Brussels 50
Chicago 45
Dublin 41
San Jose 39
Dong Ket 38
Munich 37
Rome 35
Dallas 34
Hefei 33
Reggio Emilia 33
Brno 28
Kilburn 28
Ottawa 28
Parma 28
Toronto 26
Falls Church 24
Las Vegas 24
Belize City 22
Kunming 22
Washington 21
Norwalk 20
Albuquerque 19
Verona 19
Guangzhou 18
Rimini 18
Chiswick 17
Philadelphia 17
Phoenix 16
San Francisco 15
Hounslow 14
Leawood 14
Nanjing 14
Palermo 14
Paris 14
Saint Louis 14
San Mateo 14
Wuhan 14
Los Angeles 13
Caltanissetta 12
Perugia 12
Amsterdam 11
Sacramento 11
San Giuliano Milanese 11
Nanchang 10
Romainville 10
Turin 10
Columbus 9
Frankfurt am Main 9
Jinan 9
Lappeenranta 9
Seongnam 9
Stockholm 9
Bergamo 8
Castelnuovo Rangone 8
Naples 8
San Lazzaro di Savena 8
Acton 7
Atlanta 7
Auburn Hills 7
Bangalore 7
Bengaluru 7
Correggio 7
Dongguan 7
Grafing 7
Hanoi 7
Islington 7
Totale 20.215
Nome #
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 312
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 281
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 260
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 259
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 245
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 243
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 241
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 238
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 238
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 235
HHV-6A in syncytial giant-cell hepatitis 230
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 225
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 224
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 221
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 219
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 218
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 214
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 212
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 211
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 208
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 207
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 206
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 205
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 203
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 203
Acute appendicitis in adult neutropenic patients with hematologic malignancies 202
Mucorales-specific T cells in patients with hematologic malignancies 201
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 199
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 198
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 197
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 197
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 196
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 195
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 195
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 194
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 193
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 192
B cells and herpesviruses: a model of lymphoproliferation 192
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 191
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 190
Translational challenges of human herpesvirus 6 chromosomal integration. 189
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 189
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 189
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 188
Diagnosis of aspergillosis: Role of proteomics 187
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 186
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 181
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 181
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 181
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 179
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 178
Parvoviruses in blood donors and transplant patients, Italy 178
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 177
How I treat HHV8/KSHV-related diseases in posttransplant patients. 176
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 175
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 175
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 174
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 174
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 173
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 173
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 172
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 172
Pain and emotional distress in leukemia patients at diagnosis. 172
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 172
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 171
Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity. 169
Breast Location for De Novo Extramedullary Myeloid Sarcoma 169
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis 169
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 168
Kaposi's sarcoma after liver transplantation 168
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 167
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 167
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 167
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience 166
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 166
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 166
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 165
Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals 162
Philadelphia chromosome-positive acute lymphoblastic leukemia 161
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 159
Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide 159
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 159
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 159
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response 157
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients. 157
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 156
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 156
Long-term cognitive sequelae in a case of Wernicke’s encephalopathy after allogeneic stem cell transplantation 155
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 155
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 153
Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation 152
Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries. 152
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 151
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 149
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 148
Severe pneumonia caused by Legionella pneumophila serogroup 11, Italy. 147
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 147
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 147
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 146
Early Education for Early, Integrated Palliative Medicine 146
Totale 18.692
Categoria #
all - tutte 122.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.788 0 0 0 361 590 821 1.049 745 505 227 262 228
2020/20214.535 316 228 346 500 493 435 304 513 218 556 338 288
2021/20223.733 247 433 370 185 85 173 203 181 349 315 622 570
2022/20234.019 510 454 278 366 545 502 105 429 429 74 167 160
2023/20242.910 102 141 189 267 527 275 313 437 59 90 185 325
2024/2025691 294 120 157 120 0 0 0 0 0 0 0 0
Totale 26.125